Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Some patients with metastatic clear-cell renal cancer appear to fare relatively well when treated with sunitinib before undergoing planned nephrectomy — even though…
NEW YORK (Reuters Health) – Using intra-arterial chemotherapy to treat retinoblastoma can produce a “dramatic response,” but also comes with the risk of both mild and severe side…
NEW YORK (Reuters Health) – Women who are positive for human papilloma virus (HPV) and have low-grade cervical cytological abnormalities but normal colposcopic findings are at low risk…
NEW YORK (Reuters Health) – While partial nephrectomy remains the gold standard for treatment of small renal masses, laparoscopic cryoablation is a good option for selected patients, an…
NEW YORK (Reuters Health) – Hysteroscopy using narrow-band imaging (NBI) technology may be more sensitive than white-light imaging (WLI) for diagnosing endometrial cancer and hyperplasia, hint results of…
NEW YORK (Reuters Health) – After chemotherapy-induced remission of follicular lymphoma, vaccination with a patient-specific tumor-derived antigen improves disease-free survival, a multicenter team has shown. Furthermore, the vaccine…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…
NEW YORK (Reuters Health) – Very small breast tumors that generate extensive lymph node involvement may be more biologically aggressive than larger tumors with the same degree of…
NEW YORK (Reuters Health) – Results of a meta-analysis confirm that the oral tyrosine kinase inhibitor gefitinib is effective as first-line therapy in patients with advanced non-small-cell lung…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses HPV and cervical cancer. To learn more about the Women’s Health…
